Migraine relief in kids: study reveals who responds best to propranolol
NCT ID NCT07180043
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 33 times
Summary
This study tested propranolol, a common blood pressure medicine, in 178 children aged 6 to 16 with migraines. Researchers compared it to behavioral therapy and looked for clues—like anxiety, vitamin levels, and other symptoms—that might predict which kids get the most relief. The goal is to help doctors choose the right treatment for each child.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kayseri University
Kayseri, Kayseri, 38130, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.